PharmaShots | Incisive News in 3 Shots

Subscribe Now

All Posts by Date

Takeda’s Qdenga Receives EC’s Approval for the Prevention of Dengue Disease in Patients Aged ≥4 Years

Takeda’s Qdenga Receives EC’s Approval for the Prevention of Dengue Disease in Patients Aged ≥4 Years

December 8, 2022

Top 20 Animal Health Companies Based on 2021 Revenue

Top 20 Animal Health Companies Based on 2021 Revenue

December 8, 2022

Roche Entered into Master Clinical Trial Collaboration and Supply Agreement with Replimune for RP2/3 Program to Treat Colorectal Cancer and Hepatocellular Carcinoma

Roche Entered into Master Clinical Trial Collaboration and Supply Agreement with Replimune for RP2/3 Program to Treat Colorectal C...

December 8, 2022

UCB Publishes P-III (BE OPTIMA) and (BE COMPLETE) Studies Results of Bimekizumab for Psoriatic Arthritis in The Lancet

UCB Publishes P-III (BE OPTIMA) and (BE COMPLETE) Studies Results of Bimekizumab for Psoriatic Arthritis in The Lancet

December 8, 2022

Boehringer Ingelheim and Eli Lilly Report P-III (DINAMO) Trial Results of Jardiance (empagliflozin) for the Treatment of Type 2 Diabetes at IDF 2022

Boehringer Ingelheim and Eli Lilly Report P-III (DINAMO) Trial Results of Jardiance (empagliflozin) for the Treatment of Type 2 Di...

December 8, 2022

Novartis Presents P-II (RIGHT Choice) Trial Results of Kisqali (ribociclib) as 1L Treatment of HR+/HER2− Metastatic Breast Cancer at SABCS

Novartis Presents P-II (RIGHT Choice) Trial Results of Kisqali (ribociclib) as 1L Treatment of HR+/HER2− Metastatic Breast Cancer...

December 8, 2022

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us